Table 2.
Characteristic | No. | % |
---|---|---|
Age, years | ||
Median | 60.7 | |
Range | 40-82 | |
Presurgical PSA | ||
Median | 7.8 | |
Range | 5.1-12.3 | |
Race | ||
Non-Hispanic white | 399 | 83 |
Black | 66 | 14 |
Hispanic | 25 | 5 |
Asian/Pacific Islander | 9 | 2 |
Native American | 2 | 0.5 |
Unknown | 5 | 1 |
Stage | ||
Organ confined | 110 | 23 |
≥ T3 but N0 | 292 | 61 |
N1 | 79 | 16 |
Gleason score | ||
< 7 | 9 | 2 |
7 | 215 | 45 |
8-10 | 257 | 53 |
Radiation therapy planned | ||
Yes | 130 | 27 |
No | 351 | 73 |
Positive surgical margin | ||
Yes | 316 | 66 |
No | 165 | 34 |
Abbreviations: ADT, androgen deprivation therapy; PSA, prostate-specific antigen.